慢性阻塞性肺疾病合并骨质疏松的研究进展

doi:10.3969/j.issn.1006-5725.2024.19.022

Abstract

Abstract:

Chronic obstructive pulmonary disease is characterized by progressive and partially reversible airflow restriction， and is a preventable and treatable respiratory disease. More and more attention has been paid to its complications， including osteoporosis， cardiovascular and cerebrovascular diseases， metabolic syndrome， diabetes， anxiety， depression， etc.Osteoporosis， as the main extrapulmonary complication of chronic obstructive pulmonary disease， seriously threatens the physical and mental health of patients.There are many causes of secondary osteoporosis in chronic obstructive pulmonary disease， including hypoxia， malnutrition， decreased weight and exercise ability， glucocorticoids use， smoking， etc.This article reviews the causes and treatment methods of secondary osteoporosis in chronic obstructive pulmonary disease， aiming to provide theoretical basis for the prevention and treatment of secondary osteoporosis in chronic obstructive pulmonary disease.

Key words: chronic obstructive pulmonary disease, osteoporosis, pathogenic factors, treatment

CLC Number:

R593.2

Kun WANG,Xiaomei. CAO. A review of studies on chronic obstructive pulmonary disease complicated with osteoporosis[J]. The Journal of Practical Medicine, 2024, 40(19): 2796-2800.

References 55

1	CHRISTENSON S A， SMITH B M， BAFADHEL M， et al. Chronic obstructive pulmonary disease［J］. Lancet， 2022， 399（10342）：2227-2242. doi:10.1016/s0140-6736(22)00470-6 doi: 10.1016/s0140-6736(22)00470-6
2	RITCHEY K C， YOHANNES A M， LOCKE E R， et al. Association between self-reported falling risk and risk of hospitalization for patients with chronic obstructive pulmonary disease［J］.Respir Med， 2023， 220：107466. doi:10.1016/j.rmed.2023.107466 doi: 10.1016/j.rmed.2023.107466
3	RITCHIE A I， WEDZICHA J A. Definition， Causes， Pathogenesis， and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations［J］. Clin Chest Med， 2020， 41（3）：421-438. doi:10.1016/j.ccm.2020.06.007 doi: 10.1016/j.ccm.2020.06.007
4	CASE M A， EAKIN M N. Up-to-date guidance towards improving medication adherence in patients with chronic obstructive pulmonary disease［J］. Expert Rev Respir Med， 2023， 17（7）：539-546. doi:10.1080/17476348.2023.2239708 doi: 10.1080/17476348.2023.2239708
5	JENKINS C. Differences Between Men and Women with Chronic Obstructive Pulmonary Disease［J］. Clin Chest Med， 2021， 42（3）：443-456. doi:10.1016/j.ccm.2021.06.001 doi: 10.1016/j.ccm.2021.06.001
6	JIANG R， MOU S， LUO F， et al. Causal relationship between chronic obstructive pulmonary disease and BMD at different sites： A bidirectional Mendelian randomization study［J］. Medicine （Baltimore）， 2023，102（41）：e35495. doi:10.1097/md.0000000000035495 doi: 10.1097/md.0000000000035495
7	KAENMUANG P， KEERATICHANANONT W， GEATER S L， et al. Prevalence， predictors， dynamic bone change， and treatment efficacy of osteoporosis among chronic obstructive pulmonary disease patients： a prospective cohort study［J］. Front Med （Lausanne）， 2023， 10：1214277. doi:10.3389/fmed.2023.1214277 doi: 10.3389/fmed.2023.1214277
8	ZHANG N， FAN X， ZHANG Y， et al. Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment［J］. Respir Care， 2023， 68（12）：1719-1727. doi:10.4187/respcare.10933 doi: 10.4187/respcare.10933
9	WANG H， LI S， CHEN B， et al. Exploring the shared gene signatures of smoking-related osteoporosis and chronic obstructive pulmonary disease using machine learning algorithms ［J］. Front Mol Biosci， 2023， 10：1204031. doi:10.3389/fmolb.2023.1204031 doi: 10.3389/fmolb.2023.1204031
10	JEEYAVUDEEN M S， HANSDEK S G， THOMAS N， et al. Bone health in ambulatory male patients with chronic obstructive airway disease - A case control study from India［J］. Aging Med （Milton）， 2023， 6（1）：63-70. doi:10.1002/agm2.12239 doi: 10.1002/agm2.12239
11	WILSON A C， BON J M， MASON S， et al.Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD［J］. Respir Res， 2022， 23（1）：311. doi:10.1186/s12931-022-02237-w doi: 10.1186/s12931-022-02237-w
12	NIE H， WANG F， ZENG X， et al. Analysis of Communal Molecular Mechanism Between Chronic Obstructive Pulmonary Disease and Osteoporosis［J］. Int J Chron Obstruct Pulmon Dis， 2023，18：259-271. doi:10.2147/copd.s395492 doi: 10.2147/copd.s395492
13	FIORENTINO G， ESQUINAS A M， ANNUNZIATA A. Exercise and Chronic Obstructive Pulmonary Disease （COPD）［J］. Adv Exp Med Biol， 2020， 1228：355-368. doi:10.1007/978-981-15-1792-1_24 doi: 10.1007/978-981-15-1792-1_24
14	LI Y， GAO H， ZHAO L，et al. Osteoporosis in COPD patients： Risk factors and pulmonary rehabilitation［J］.Clin Respir J， 2022， 16（7）：487-496. doi:10.1111/crj.13514 doi: 10.1111/crj.13514
15	ZHANG L， SUN Y. Muscle-Bone Crosstalkin Chronic Obstructive Pulmonary Disease ［J］. Front Endocrinol （Lausanne）， 2021，12：724911. doi:10.3389/fendo.2021.724911 doi: 10.3389/fendo.2021.724911
16	张宁，夏晓黎，王亚锋，等. 慢性阻塞性肺疾病合并骨质疏松症危险因素的Meta分析［J］. 医学信息， 2022， 35（24）： 108-114. doi:10.3969/j.issn.1006-1959.2022.24.020 doi: 10.3969/j.issn.1006-1959.2022.24.020
17	邹华，刘春磊. 骨折联络服务干预慢性阻塞性肺疾病伴老年性骨质疏松症椎体再骨折的临床研究［J］. 临床研究， 2023， 31 （7）： 18-21.
18	CIROVIC A， DENIC A， CLARKE B L， et al. A hypoxia-driven occurrence of chronic kidney disease and osteoporosis in COPD individuals： New insights into environmental cadmium exposure［J］. Toxicology， 2022， 482：153355. doi:10.1016/j.tox.2022.153355 doi: 10.1016/j.tox.2022.153355
19	LODGE K M， VASSALLO A， LIU B， et al. Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease［J］.Am J Respir Crit Care Med， 2022， 205（8）：903-916. doi:10.1164/rccm.202006-2467oc doi: 10.1164/rccm.202006-2467oc
20	黄元声，杨民，谢加兵. 缺氧及缺氧复氧环境对成骨细胞活力、凋亡及相关基因表达的影响［J］. 齐齐哈尔医学院学报，2021，42（13）：1110-1113. doi:10.3969/j.issn.1002-1256.2021.13.002 doi: 10.3969/j.issn.1002-1256.2021.13.002
21	DE MARTINIS M， ALLEGRA A， SIRUFO M M， et al. Vitamin D deficiency， osteoporosis and effect on autoimmune diseases and hematopoiesis： a review［J］. Int J Mol Sci， 2021， 22（16）： 8855. doi:10.3390/ijms22168855 doi: 10.3390/ijms22168855
22	其其格，夏丽华，任睿. 地黄多糖上调miR-216a表达对缺氧/复氧诱导的肾小管上皮细胞氧化应激和细胞凋亡的影响［J］. 沈阳药科大学学报， 2023， 40（11）： 1466-1472+1576.
23	WANG J， ZHAO B， CHE J， et al. Hypoxia Pathway in Osteoporosis： Laboratory Data for Clinical Prospects［J］. Int J Environ Res Public Health， 2023， 20（4）：3129. doi:10.3390/ijerph20043129 doi: 10.3390/ijerph20043129
24	WENG W， LI H， ZHU S. An Overlooked Bone Metabolic Disorder： Cigarette Smoking-Induced Osteoporosis［J］.Genes （Basel）， 2022， 13（5）：806. doi:10.3390/genes13050806 doi: 10.3390/genes13050806
25	沈鹏远，周庆，钟磊. 预后营养指数与慢性阻塞性肺疾病患者预后的关系［J］. 中国现代医生， 2023， 61（22）： 18-21. doi:10.3969/j.issn.1673-9701.2023.22.005 doi: 10.3969/j.issn.1673-9701.2023.22.005
26	利海波，黄玉龙，潘燕碟. 海南省某市COPD合并骨质疏松患者营养状况及其影响因素分析［J］.中国骨质疏松杂志，2018，24（4）：495-499.
27	李冬祎，王炜，赵真，等. 老年男性慢阻肺患者骨质疏松相关危险因素分析［J］. 临床肺科杂志，2019，24（4）：645-649. doi:10.3969/j.issn.1009-6663.2019.04.015 doi: 10.3969/j.issn.1009-6663.2019.04.015
28	GRAUMAM R Q， PINHEIRO M M， NERY L E， et al. Increased rate of osteoporosis， low lean mass， and fragility fractures in COPD patients： association with disease severity［J］.Osteoporos Int， 2018， 29（6）：1457-1468. doi:10.1007/s00198-018-4483-z doi: 10.1007/s00198-018-4483-z
29	郑华东，岳斌，杜洁，等. 老年男性慢性阻塞性肺病对骨质疏松影响的研究［J］. 陕西医学杂志，2017，46（11）：1539-1541. doi:10.3969/j.issn.1000-7377.2017.11.016 doi: 10.3969/j.issn.1000-7377.2017.11.016
30	CHEN H， DENG Z X， SUN J， et al. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD： A Meta-analysis of 60 Randomized Controlled Trials［J］. Chest， 2023， 163（1）：100-114. doi:10.1016/j.chest.2022.07.015 doi: 10.1016/j.chest.2022.07.015
31	LI Y， GAO H， ZHAO L， et al. Osteoporosis in COPD patients： Risk factors and pulmonary rehabilitation［J］. Clin Respir J， 2022， 16（7）：487-496. doi:10.1111/crj.13514 doi: 10.1111/crj.13514
32	ZAVATTA G， CLARKE B L. Glucocorticoid- and Transplantation-Induced Osteoporosis［J］. Endocrinol Metab Clin North Am， 2021， 50（2）：251-273. doi:10.1016/j.ecl.2021.03.002 doi: 10.1016/j.ecl.2021.03.002
33	CARAMORI G， RUGGERI P， ARPINELLI F， et al. Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures： a narrative review of the literature［J］. Int J Chron Obstruct Pulmon Dis， 2019， 14：1085-1097. doi:10.2147/copd.s190215 doi: 10.2147/copd.s190215
34	GONÇALVES P A， DOS SANTOS NEVES R， NETO L V， et al. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients［J］. J Bone Miner Metab， 2018， 36（4）：454-461. doi:10.1007/s00774-017-0854-3 doi: 10.1007/s00774-017-0854-3
35	尹艳榕，陈婧瑜，钟文玲，等. 福建省40岁及以上男性吸烟人群慢性阻塞性肺疾病患病相关因素分析［J］. 中国慢性病预防与控制， 2023， 31（8）： 597-600.
36	JING Z， LI Y， ZHANG H， et al. Tobacco toxins induce osteoporosis through ferroptosis［J］. Redox Biol， 2023， 67：102922. doi:10.1016/j.redox.2023.102922 doi: 10.1016/j.redox.2023.102922
37	HOU W， CHEN S， ZHU C， et al. Associations between smoke exposure and osteoporosis or osteopenia in a US NHANES population of elderly individuals［J］. Front Endocrinol （Lausanne）， 2023，14：1074574. doi:10.3389/fendo.2023.1074574 doi: 10.3389/fendo.2023.1074574
38	ZYSMAN M， RAHERISON-SEMJEN C. Women's COPD［J］. Front Med （Lausanne）， 2022， 8：600107. doi:10.3389/fmed.2021.600107 doi: 10.3389/fmed.2021.600107
39	INOUE D， WATANABE R， OKAZAKI R. COPD and osteoporosis： links， risks， and treatment challenges［J］.Int J Chron Obstruct Pulmon Dis， 2016， 11：637-648. doi:10.2147/copd.s79638 doi: 10.2147/copd.s79638
40	彭海斌. COPD患者高密度脂蛋白胆固醇水平与骨质疏松症的相关性研究［J］. 临床肺科杂志，2014，19（2）：315-317. doi:10.3969/j.issn.1009-6663.2014.02.042 doi: 10.3969/j.issn.1009-6663.2014.02.042
41	李俏俏. 不同分期的COPD患者并发骨质疏松的相关因素分析［J］. 医学研究杂志， 2014， 43（8）：150-155.
42	李进勇，曾玮. 沙美特罗氟替卡松对急性加重期COPD患者骨代谢以及气道重塑的影响分析［J］. 临床和实验医学杂志，2017，16（14）：1406-1410. doi:10.3969/j.issn.1671-4695.2017.14.019 doi: 10.3969/j.issn.1671-4695.2017.14.019
43	张未，关蔚蔚，姜静. 老年男性慢性阻塞性肺疾病患者并发骨质疏松症与血清睾酮水平的关系［J］. 中华骨质疏松和骨矿盐疾病杂志，2017，10（6）：535-540. doi:10.3969/j.issn.1674-2591.2017.06.007 doi: 10.3969/j.issn.1674-2591.2017.06.007
44	陈剑颖. 老年COPD稳定期合并骨质疏松的易患因素分析［J］.白求恩医学杂志，2017，15（4）：426-428.
45	陈兰波，顾小红. 血清睾酮水平与老年男性COPD合并骨质疏松症的相关性研究［J］. 重庆医科大学学报，2018，43（6）：768-771.
46	NICOLINI A， BARBAGELATA E， TAGLIABUE E， et al. Gender differences in chronic obstructive pulmonary diseases： a narrative review［J］. Panminerva Med，2018，60（4）：192-199. doi:10.23736/s0031-0808.18.03463-8 doi: 10.23736/s0031-0808.18.03463-8
47	RODRÍGUEZ-GÓMEZ I， GRAY S R， HO F K， et al. Osteoporosis and Its Association With Cardiovascular Disease， Respiratory Disease， and Cancer： Findings From the UK Biobank Prospective Cohort Study［J］. Mayo Clin Proc， 2022， 97（1）：110-121. doi:10.1016/j.mayocp.2021.07.019 doi: 10.1016/j.mayocp.2021.07.019
48	朱庆华，何小花，黄青青. 阿托伐他汀钙治疗绝经后慢性阻塞性肺疾病合并骨质疏松症患者的疗效及对激素水平的影响［J］. 中国妇幼保健，2021，36（12）：2735-2737.
49	刘凌琳，章陈晨，熊玮. 阿仑膦酸钠联合钙尔奇D治疗COPD合并骨质疏松的疗效及对肺功能的影响［J］. 中国老年学杂志，2021，41（16）：3426-3429. doi:10.3969/j.issn.1005-9202.2021.16.011 doi: 10.3969/j.issn.1005-9202.2021.16.011
50	杜娟，管慧，刘英，等. 鲑鱼降钙素联合糖皮质激素吸入治疗COPD合并骨质疏松的疗效及对血清PINP、β-CTX、MMP-9水平的影响［J］. 现代生物医学进展，2019，19（14）：2767-2770，2725.
51	何浩森，陈嘉馨，彭炜，等. 鲑鱼降钙素联合补肾宣肺汤治疗慢性阻塞性肺疾病患者骨质疏松［J］. 实用医学杂志，2017，33（3）：484-486. doi:10.3969/j.issn.1006-5725.2017.03.041 doi: 10.3969/j.issn.1006-5725.2017.03.041
52	陈颖，何柳柳，邓伟民，等. 唑来膦酸治疗原发性骨质疏松症的长期疗效［J］. 实用医学杂志， 2023， 39（10）： 1278-1284. doi:10.3969/j.issn.1006-5725.2023.10.016 doi: 10.3969/j.issn.1006-5725.2023.10.016
53	徐丽敏，方昌全，麦辉，等. 唑来膦酸治疗慢阻肺患者骨质疏松症的疗效及对OPG、RANKL表达的影响［J］. 临床肺科杂志，2022，27（7）：1077-1079，1085. doi:10.3969/j.issn.1009-6663.2022.07.020 doi: 10.3969/j.issn.1009-6663.2022.07.020
54	邹华，刘春磊. 经皮椎体成形术治疗慢性阻塞性肺疾病合并骨质疏松椎体骨折的临床研究［J］. 骨科，2022，13（2）：121-124. doi:10.3969/j.issn.1674-8573.2022.02.005 doi: 10.3969/j.issn.1674-8573.2022.02.005
55	罗清，许光兰，陈平，等. 综合方法预防COPD合并骨质疏松症（OP）患者发生OCVF的初步观察［J］. 中国骨质疏松杂志，2018，24（4）：479-482. doi:10.3969/j.issn.1006-7108.2018.04.012 doi: 10.3969/j.issn.1006-7108.2018.04.012

[1]	Shifang YANG,Xinglin GAO,Jing LI,Lupeng. JI. Sarcopenia associated with chronic obstructive pulmonary disease [J]. The Journal of Practical Medicine, 2024, 40(9): 1181-1185.
[2]	Qiaofang HUANG,Xingxiao HUANG,Junyi LIN,Lian DUAN,Zhentai PANG,Shaojuan WU,Caimei ZOU,Shichao XU. Effect of physician⁃nurse⁃social worker linkage rehabilitation model on psychological status in patients receiving methadone maintenance treatment [J]. The Journal of Practical Medicine, 2024, 40(9): 1238-1243.
[3]	Tianyue CUI,Liquan OUYANG,Shengchu. ZHANG. Clinical efficacy of simple surgery and surgery combined with glucocorticoids in the treatment of mass type granulomatous mastitis [J]. The Journal of Practical Medicine, 2024, 40(9): 1268-1274.
[4]	Shuangyan LI,Bin ZHANG. Research status and challenges of insomnia disorder [J]. The Journal of Practical Medicine, 2024, 40(6): 731-737.
[5]	Yuxin CHENG,Liang LIU,Shiyu DONG,Shengchao LI,Meng ZHANG. Research advances in exosomal proteins， mRNA and non⁃coding RNA regulation of Hepatocellular Carcinoma [J]. The Journal of Practical Medicine, 2024, 40(6): 748-755.
[6]	Pengshuai SUN,Feng ZHU,Lihong ZHENG,Haiqiang WANG. Research progress in the treatment of AMPK regulating lipid accumulation in the treatment of nonalcoholic fatty liver disease [J]. The Journal of Practical Medicine, 2024, 40(6): 862-866.
[7]	Rui XU,Xingbing. HUANG. Progress of non-pharmacological treatments for treatment-resistant depression [J]. The Journal of Practical Medicine, 2024, 40(4): 439-446.
[8]	Yigang TAN,Haobin KUANG,Hongmei FU,Chunyan LI,Xiaobing ZHAO,Lijing XUE. Analysis of clinical characteristics of 33 cases of tuberculosis complicated by tumor necrosis factor⁃α inhibitor in autoimmune diseases [J]. The Journal of Practical Medicine, 2024, 40(3): 378-383.
[9]	Zhen WANG,Lianjin GUO,Jiarong LIANG,Haoyi YE,Xunmeng. ZHANG. Value of MRI fat quantification parameter combined with 25⁃hydroxyvitamin D in predicting fracture risk in patients with osteoporosis [J]. The Journal of Practical Medicine, 2024, 40(22): 3238-3243.
[10]	Menglu ZHU,Fengjiao ZHANG,Zhiqiang KANG. Effects of telomere length and plasma AGEs on bone mineral density in type 2 diabetic patients [J]. The Journal of Practical Medicine, 2024, 40(20): 2860-2866.
[11]	Xiuhua YANG,Yongling YANG,Zhen ZHANG,Jianjun LONG,Tao CHENG,Jian CHEN,Cunhao TIAN. Epidemiological study on common congenital heart disease in children in ethnic minority areas in southeastern Guizhou and influencing factors of delayed medical treatment [J]. The Journal of Practical Medicine, 2024, 40(2): 253-260.
[12]	Honglin GU,Xiaoqing ZHENG,Changxiang LIANG,Dan XIAO,Shixing ZENG,Yunbing. CHANG. Surgical strategy and early efficacy of biportal endoscopic transforaminal lumbar interbody fusion for lumbar spondylolisthesis with osteoporosis [J]. The Journal of Practical Medicine, 2024, 40(19): 2696-2702.
[13]	Bin ZHANG,Wei HU,Rongzhen TAN,Panpan YANG,Jun HU,Zhong YUAN,Gongtao. JIANG. Effects of Yishen Huayu Xugu prescription combined with Dixumab on IL-6， β-CTX and bone mineral density in elderly patients operated for osteoporotic lumbar vertebral compression fractures [J]. The Journal of Practical Medicine, 2024, 40(19): 2766-2771.
[14]	Qingwei ZHANG,Rutie. YIN. Hotspots and advances on diagnosis and treatment for cervical cancer [J]. The Journal of Practical Medicine, 2024, 40(17): 2357-2362.
[15]	Mingyu YAO,He ZHU,Yizhi DONG,Xinyue SONG,Yaxin DU,Ruixia WU,Yong. ZHU. Study on the efficacy of Schroth PSSE combined with 3D printing brace in the treatment of adolescent idiopathic scoliosis [J]. The Journal of Practical Medicine, 2024, 40(17): 2440-2448.

A review of studies on chronic obstructive pulmonary disease complicated with osteoporosis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 55

Related Articles 15

Recommended Articles

Metrics

Comments